These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 190361)
21. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches. Juratli TA; Schackert G; Krex D Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764 [TBL] [Abstract][Full Text] [Related]
22. Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant gliomas: a phase II study. Watanabe K; Kanaya H; Fujiyama Y; Kim P Acta Neurochir (Wien); 2002 Dec; 144(12):1265-70; discussion 1270. PubMed ID: 12478337 [TBL] [Abstract][Full Text] [Related]
23. Lipid association improves the therapeutic index of lomustine [1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea] to suppress 36B-10 tumor growth in rats. Bethune CR; Geyer RJ; Spence AM; Ho RJ Cancer Res; 2001 May; 61(9):3669-74. PubMed ID: 11325837 [TBL] [Abstract][Full Text] [Related]
24. DTIC (nsc-45388) and combination therapy for melanoma. I. Studies with DTIC, BCNU (NSC-409962), CCNU (NSC-79037), vincristine (NSC-67574), and hydroxyurea (NSC-32065). Carter RD; Krementz ET; Hill GJ; Metter GE; Fletcher WS; Golomb FM; Grage TB; Minton JP; Sparks FC Cancer Treat Rep; 1976 May; 60(5):601-9. PubMed ID: 991149 [TBL] [Abstract][Full Text] [Related]
25. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas. Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859 [TBL] [Abstract][Full Text] [Related]
26. In vitro evaluation of in vivo brain tumor chemotherapy with 1,3-bis(2-chloroethyl)-1-nitrosourea. Rosenblum ML; Wheeler KT; Wilson CB; Barker M; Knebel KD Cancer Res; 1975 Jun; 35(6):1387-91. PubMed ID: 1131813 [TBL] [Abstract][Full Text] [Related]
27. Multi-drug versus single agent chemotherapy for high grade astrocytoma; results of a meta-analysis. Huncharek M; Muscat J; Geschwind JF Anticancer Res; 1998; 18(6B):4693-7. PubMed ID: 9891542 [TBL] [Abstract][Full Text] [Related]
28. Evaluation of a "nude" mouse-human tumor panel as a predictive secondary screen for cancer chemotherapeutic agents. Bellet RE; Danna V; Mastrangelo MJ; Berd D J Natl Cancer Inst; 1979 Nov; 63(5):1185-8. PubMed ID: 91697 [TBL] [Abstract][Full Text] [Related]
29. High-dose BCNU followed by autologous hematopoietic stem cell transplantation in supratentorial high-grade malignant gliomas: a retrospective analysis of 114 patients. Durando X; Lemaire JJ; Tortochaux J; Van-Praagh I; Kwiatkowski F; Vincent C; Bailly C; Verrelle P; Irthum B; Chazal J; Bay JO Bone Marrow Transplant; 2003 Apr; 31(7):559-64. PubMed ID: 12692621 [TBL] [Abstract][Full Text] [Related]
31. Assay of anticancer drugs in tissue culture: cell cultures of biopsies from human astrocytoma. Morgan D; Freshney RI; Darling JL; Thomas DG; Celik F Br J Cancer; 1983 Feb; 47(2):205-14. PubMed ID: 6297528 [TBL] [Abstract][Full Text] [Related]
33. Individual human tumors in short-term micro-organ cultures: chemosensitivity testing by fluorescent cytoprinting. Rotman B; Teplitz C; Dickinson K; Cozzolino JP In Vitro Cell Dev Biol; 1988 Nov; 24(11):1137-46. PubMed ID: 3192508 [TBL] [Abstract][Full Text] [Related]
34. Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas. Kaaijk P; Troost D; de Boer OJ; Van Amstel P; Bakker PJ; Leenstra S; Bosch DA Br J Cancer; 1996 Jul; 74(2):187-93. PubMed ID: 8688320 [TBL] [Abstract][Full Text] [Related]
35. The influence of preoperative administration of methotrexate on the outgrowth of meningiomas and astrocytomas in tissue culture. Bots GT Acta Neurochir (Wien); 1980; 54(3-4):201-4. PubMed ID: 7446230 [No Abstract] [Full Text] [Related]
36. Assay of anti-cancer drugs in tissue culture: relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma. Thomas DG; Darling JL; Paul EA; Mott TJ; Godlee JN; Tobias JS; Capra LG; Collins CD; Mooney C; Bozek T Br J Cancer; 1985 Apr; 51(4):525-32. PubMed ID: 3978031 [TBL] [Abstract][Full Text] [Related]
37. Chemotherapy for malignant gliomas of the brain: a review of ten-years experience. Paoletti P; Butti G; Knerich R; Gaetani P; Assietti R Acta Neurochir (Wien); 1990; 103(1-2):35-46. PubMed ID: 2360465 [TBL] [Abstract][Full Text] [Related]
38. Brain tumor chemotherapy using a rat glioma model. Tamura M; Mennel HD; Zülch KJ J Cancer Res Clin Oncol; 1979 May; 94(1):39-46. PubMed ID: 468898 [TBL] [Abstract][Full Text] [Related]
39. Chemotherapeutic trials on human malignant astrocytomas in organ culture. Saez RJ; Campbell RJ; Laws ER J Neurosurg; 1977 Mar; 46(3):320-7. PubMed ID: 190361 [TBL] [Abstract][Full Text] [Related]
40. BCNU (NSC-409962) and procarbazine (NSC-77213) treatment for malignant brain tumors. Levin VA; Crafts DC; Wilson CB; Schultz MJ; Boldrey EB; Enot KJ; Pischer TL; Seager M; Elashoff RM Cancer Treat Rep; 1976 Mar; 60(3):243-9. PubMed ID: 177210 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]